{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:40:50Z","timestamp":1769010050640,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10067-023-06630-8","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:11:38Z","timestamp":1684854698000},"page":"2369-2376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-5099","authenticated-orcid":false,"given":"Suling","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziye","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6053-5571","authenticated-orcid":false,"given":"Yang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"6630_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D (2017) Axial spondyloarthritis. Lancet 390:73\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(16)31591-4","journal-title":"Lancet"},{"key":"6630_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","volume":"17","author":"PC Robinson","year":"2021","unstructured":"Robinson PC, van der Linden S, Khan MA, Taylor WJ (2021) Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol 17:109\u2013118. https:\/\/doi.org\/10.1038\/s41584-020-00552-4","journal-title":"Nat Rev Rheumatol"},{"key":"6630_CR3","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A et al (2019) 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 71:1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheumatol"},{"key":"6630_CR4","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J et al (2015) Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med 373:2534\u20132548. https:\/\/doi.org\/10.1056\/NEJMoa1505066","journal-title":"N Engl J Med"},{"key":"6630_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76:978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","journal-title":"Ann Rheum Dis"},{"key":"6630_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.autrev.2015.01.011","volume":"14","author":"F Cantini","year":"2015","unstructured":"Cantini F, Nannini C et al (2015) Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev 14:503\u2013509. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.011","journal-title":"Autoimmun Rev"},{"key":"6630_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ptt.S108209","volume":"7","author":"MV Cannizzaro","year":"2017","unstructured":"Cannizzaro MV, Franceschini C, Esposito M, Bianchi L, Giunta A (2017) Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management. Psoriasis 7:35\u201340. https:\/\/doi.org\/10.2147\/ptt.S108209","journal-title":"Psoriasis"},{"key":"6630_CR8","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.cgh.2018.04.033","volume":"16","author":"MP Pauly","year":"2018","unstructured":"Pauly MP, Tucker LY et al (2018) Incidence of hepatitis B virus reactivation and hepatotoxicity in patients receiving long-term treatment with tumor necrosis factor antagonists. Clin Gastroenterol Hepatol 16:1964-1973.e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6630_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamadermatol.2020.3257","volume":"157","author":"BE Elewski","year":"2021","unstructured":"Elewski BE, Baddley JW et al (2021) Association of secukinumab treatment with tuberculosis reactivation in patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis. JAMA Dermatol 157:43\u201351. https:\/\/doi.org\/10.1001\/jamadermatol.2020.3257","journal-title":"JAMA Dermatol"},{"key":"6630_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jdv.16254","volume":"34","author":"E Fowler","year":"2020","unstructured":"Fowler E, Ghamrawi RI, Ghiam N, Liao W, Wu JJ (2020) Risk of tuberculosis reactivation during interleukin-17 inhibitor therapy for psoriasis: a systematic review. J Eur Acad Dermatol Venereol 34:1449\u20131456. https:\/\/doi.org\/10.1111\/jdv.16254","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6630_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2340\/00015555-2989","volume":"98","author":"HY Chiu","year":"2018","unstructured":"Chiu HY, Hui RC et al (2018) Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: a multicentric prospective cohort study. Acta Derm Venereol 98:829\u2013834. https:\/\/doi.org\/10.2340\/00015555-2989","journal-title":"Acta Derm Venereol"},{"key":"6630_CR12","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00296-011-1934-7","volume":"32","author":"B Zheng","year":"2012","unstructured":"Zheng B, Li T et al (2012) Prevalence of hepatitis B surface antigen in patients with ankylosing spondylitis and its association with HLA-B27: a retrospective study from south China. Rheumatol Int 32:2011\u20132016. https:\/\/doi.org\/10.1007\/s00296-011-1934-7","journal-title":"Rheumatol Int"},{"key":"6630_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3760\/cma.j.issn.0376-2491.2019.01.005","volume":"99","author":"YJ Liu","year":"2019","unstructured":"Liu YJ, Xu J et al (2019) The prevalence of latent tuberculosis infection in patients with inflammatory arthritis and the diagnostic efficacy of different screening methods. Zhonghua Yi Xue Za Zhi 99:20\u201324. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2019.01.005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"6630_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"6630_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40257-019-00457-3","volume":"20","author":"S Piaserico","year":"2019","unstructured":"Piaserico S, Messina F, Russo FP (2019) Managing psoriasis in patients with HBV or HCV infection: practical considerations. Am J Clin Dermatol 20:829\u2013845. https:\/\/doi.org\/10.1007\/s40257-019-00457-3","journal-title":"Am J Clin Dermatol"},{"key":"6630_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/resp.13346","volume":"23","author":"CBE Chee","year":"2018","unstructured":"Chee CBE, Reves R, Zhang Y, Belknap R (2018) Latent tuberculosis infection: opportunities and challenges. Respirology 23:893\u2013900. https:\/\/doi.org\/10.1111\/resp.13346","journal-title":"Respirology"},{"key":"6630_CR17","doi-asserted-by":"publisher","first-page":"8909834","DOI":"10.1155\/2017\/8909834","volume":"2017","author":"F Cantini","year":"2017","unstructured":"Cantini F, Nannini C et al (2017) Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics. Mediators Inflamm 2017:8909834. https:\/\/doi.org\/10.1155\/2017\/8909834","journal-title":"Mediators Inflamm"},{"key":"6630_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccm.2019.07.007","volume":"40","author":"MK Haas","year":"2019","unstructured":"Haas MK, Belknap RW (2019) Diagnostic tests for latent tuberculosis infection. Clin Chest Med 40:829\u2013837. https:\/\/doi.org\/10.1016\/j.ccm.2019.07.007","journal-title":"Clin Chest Med"},{"key":"6630_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1086\/338149","volume":"34","author":"E Lee","year":"2002","unstructured":"Lee E, Holzman RS (2002) Evolution and current use of the tuberculin test. Clin Infect Dis 34:365\u2013370. https:\/\/doi.org\/10.1086\/338149","journal-title":"Clin Infect Dis"},{"key":"6630_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/s1473-3099(04)01206-x","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4:761\u2013776. https:\/\/doi.org\/10.1016\/s1473-3099(04)01206-x","journal-title":"Lancet Infect Dis"},{"key":"6630_CR21","doi-asserted-by":"publisher","first-page":"m2200","DOI":"10.1136\/bmj.m2200","volume":"370","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng M (2020) Hepatitis B virus persistence and reactivation. Bmj 370:m2200. https:\/\/doi.org\/10.1136\/bmj.m2200","journal-title":"Bmj"},{"key":"6630_CR22","doi-asserted-by":"publisher","first-page":"745592","DOI":"10.3389\/fmicb.2021.745592","volume":"12","author":"W Gong","year":"2021","unstructured":"Gong W, Wu X (2021) Differential diagnosis of latent tuberculosis infection and active tuberculosis: a key to a successful tuberculosis control strategy. Front Microbiol 12:745592. https:\/\/doi.org\/10.3389\/fmicb.2021.745592","journal-title":"Front Microbiol"},{"key":"6630_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40261-022-01163-5","volume":"42","author":"M Megna","year":"2022","unstructured":"Megna M, Patruno C et al (2022) Hepatitis virus reactivation in patients with psoriasis treated with secukinumab in a real-world setting of hepatitis B or hepatitis C infection. Clin Drug Investig 42:525\u2013531. https:\/\/doi.org\/10.1007\/s40261-022-01163-5","journal-title":"Clin Drug Investig"},{"key":"6630_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1684\/ejd.2022.4263","volume":"32","author":"H Qin","year":"2022","unstructured":"Qin H, Liu N et al (2022) Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study. Eur J Dermatol 32:394\u2013400. https:\/\/doi.org\/10.1684\/ejd.2022.4263","journal-title":"Eur J Dermatol"},{"key":"6630_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"EASL","year":"2017","unstructured":"EASL (2017) Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67:370\u2013398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"key":"6630_CR26","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1080\/09546634.2022.2062280","volume":"33","author":"M Megna","year":"2022","unstructured":"Megna M, Patruno C et al (2022) Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection. J Dermatolog Treat 33:2629\u20132633. https:\/\/doi.org\/10.1080\/09546634.2022.2062280","journal-title":"J Dermatolog Treat"},{"key":"6630_CR27","doi-asserted-by":"publisher","first-page":"e14512","DOI":"10.1111\/dth.14512","volume":"33","author":"D Shu","year":"2020","unstructured":"Shu D, Zhang Z, Zhou EY, Ma X, Zhao Y (2020) Is chemoprophylaxis necessary for all latent tuberculosis infection patients receiving IL-17 inhibitors? A cohort study. Dermatol Ther 33:e14512. https:\/\/doi.org\/10.1111\/dth.14512","journal-title":"Dermatol Ther"},{"key":"6630_CR28","doi-asserted-by":"publisher","first-page":"36923","DOI":"10.1038\/srep36923","volume":"6","author":"N Segueni","year":"2016","unstructured":"Segueni N, Tritto E et al (2016) Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNF\u03b1 neutralization. Sci Rep 6:36923. https:\/\/doi.org\/10.1038\/srep36923","journal-title":"Sci Rep"},{"key":"6630_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1478-3231.2012.02764.x","volume":"32","author":"Z Huang","year":"2012","unstructured":"Huang Z, van Velkinburgh JC, Ni B, Wu Y (2012) Pivotal roles of the interleukin-23\/T helper 17 cell axis in hepatitis B. Liver Int 32:894\u2013901. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02764.x","journal-title":"Liver Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06630-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:08:15Z","timestamp":1691579295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06630-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6630"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06630-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the institutional review board of Guangdong Provincial People\u2019s Hospital with the ethics number of KY-Q-2021\u2013164 and was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was waived because the data were collected retrospectively and only anonymized data were used in the analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}